Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Schistosomiasis and Strongyloidiasis in African Refugees

    Refugees resettling to the united states and other developed countries frequently suffer from infectious diseases, and can pose diagnostic or therapeutic dilemmas for health care providers in their new homes.
  • Full March 2008 Issue in PDF

  • Pharmacology Watch: FDA Heightens Warnings on Chantix

    In this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
  • Childhood Obesity — A Looming Disaster

    This remarkable study is a population analysis of a huge cohort of children in Denmark who were followed, since 1930 or later, for the presence of coronary heart disease (CHD), and had all mandatory annual examinations at schools in Copenhagen. The study analyzed data from 277,000 children, aged 7-13.
  • Product pipeline

    CryoCor (San Diego) reported the publication of a European study of atrial fibrillation (AF) patients treated with its Cardiac Cryoablation System to evaluate the role of atrial flutter (AFl) in the recurrence of AF and the effectiveness of an ablation strategy focused on isolating the pulmonary veins to treat the AF.
  • St. Jude wins clearance for new EnSite Fusion modeling software

    St. Jude Medical (St. Paul, Minnesota) reported FDA clearance of its EnSite Fusion Registration Module, new software designed to aid in creating detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including atrial fibrillation (AF).
  • Personnel File

    ATS Medical; Cambridge Heart; Coherex Medical; Escalon Medical; FlowCardia; Heartscape Technologies; InterCure; TherOx
  • Market updates

    Catheter ablation reduced the number of shocks delivered to patients who have defibrillators implanted after heart attacks, concluded a study published in late last month in the "New England Journal of Medicine".
  • Agreements

    Beckman Coulter; Thomas Jefferson University; Laboraf Diagnostica e Ricerca San Raffaele SpA; BioSphere Medical; DuPont Applied BioSciences; GE Healthcare; Draximage; Draxis Health; HemCon Medical Technologies; AutoMedx; Toshiba Medical Systems; TomTec Imaging Systems
  • Acquisitions

    Edwards Lifesciences; CardioVations Division of Ethicon; C.R. Bard; LeMaitre Vascular; Biomateriali; Sorin Group; MedCath; Heart Hospital of Lafayette; Heart Hospital of Acadiana; Volcano; CardioSpectra